Utidelone

DB17575InvestigationalSmall molecule

Utidelone (UTD1), a novel microtubule stabilizing agent, is an epothilone B analogue produced by genetic engineering. It is under investigation in clinical trials for various cancers.

Mechanism: Pharmacologically active on Tubulin
Curator reviewed
Code names: UTD1

Resolves to

Clinical / RWD

ATCL01DC05

Targets

O75762TRPA1

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

38Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 4 drug categories

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Utidelone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account